Finn's Take· TL;DRThe ads make it look simple: take the injection, lose the weight, reclaim your life. But for a growing number of women on GLP-1 medications like Ozempic, Wegovy, and Mounjaro, the reality has been far messier — and far less glamorous. Hundreds of women responded to a Reddit inquiry from a 58-year-old woman who wanted honest, authentic information about the medication's side effects. What poured in was a flood of raw, unfiltered testimony that the polished marketing materials never mention.
The most striking theme? The experience of feeling like a miserable first-trimester pregnancy — without the baby. "It felt a lot like morning sickness. Nausea, constipation, food aversions. Sure, I lost a little weight, but only because I felt so awful I didn't want to eat." Another user described feeling miserable the entire time she was on GLP-1s. Some women stayed on the medication far longer than they should have, driven by desperation to see results that never came — one woman reported actually gaining weight, staying on it longer than she should have because she desperately wanted her blood glucose levels to go down.
Many users reported severe gastrointestinal side effects, including nausea and vomiting, with symptoms persisting for days after each injection. One user mentioned damage to their tooth enamel due to frequent vomiting — a consequence that can have lasting dental consequences. Several women also reported developing gallstones or experiencing gallbladder attacks, with some requiring surgery. One user described becoming so iron-deficient that she needed an infusion on top of her gallbladder ordeal.
The side effects extend well beyond the gut. Reports included feelings of depression, irritability, and a constant sense of being weighed down. Hair thinning and worsening skin appearance were also noted, along with what some called "GLP-1 face" — a visible deterioration in skin quality. A few women reported feeling colder than usual, with one describing it as an ice-cold sensation , particularly on injection days. On injection days, some women developed nausea, burping, and heartburn depending on what they ate, and found they had to pamper themselves with hot showers, antacids, and early, mild meals just to get through the evening.
The disparity between how men and women experience these drugs is significant — and largely underreported. Women experience nausea and vomiting at 2.5 times the rate of men on GLP-1 medications like semaglutide and tirzepatide, and this gap is not explained by dosing differences alone. Higher GLP-1 receptor expression in brain regions that regulate nausea, combined with estrogen's role in amplifying drug response, creates a physiologically distinct experience that clinical trial summaries rarely surface.
Muscle loss is one of the most consequential and least-discussed trade-offs of GLP-1 treatment. Muscle mass can decrease by up to 40% of total weight lost during treatment without resistance exercise, and because women have lower baseline lean mass than men, this depletion has an outsized effect on metabolism, bone density, and long-term weight maintenance. In other words, the number on the scale may drop, but what's being lost isn't always fat.
To be fair, the Reddit thread wasn't uniformly grim. Despite the challenges, some users found GLP-1s life-changing, citing improved mobility and energy from weight loss, as well as reduced migraines and improved executive functioning. Some women noticed meaningful changes in their taste preferences, with certain foods becoming less emotionally loaded — one user described having a "newborn's palate" and being able to taste food without the pull of emotional associations.
The larger takeaway from this viral conversation isn't that GLP-1s are universally bad — it's that women deserve the full picture before they start. GLP-1 side effects in women don't follow a single script. They're shaped by hormones, body composition, reproductive status, and metabolic history — meaning two women on the same semaglutide dose can feel completely different by day three. As these medications continue to dominate both medicine and pop culture, the push for more honest, women-centered conversations about their real-world effects is only going to grow louder.